Author name: Bruno Ramalho

CTNNB1 Foundation Newsletter – May 2025 Edition

Dear CTNNB1 community, This month has been a whirlwind of looming deadlines and promising milestones—most excitingly, we’re edging ever closer to the start of clinical trials. Knowing the finish line is in sight fuels us every day. We hope you enjoyed restorative holidays with loved ones and are ready for what’s next. With the CTNNB1 Conference just

CTNNB1 Foundation Newsletter – May 2025 Edition Read More »

Slovenia Awards €1M to CTNNB1 Foundation – A Breakthrough for Rare Disease Treatment

We’re thrilled to share groundbreaking news: the Slovenian government has awarded €1 million in public funding to the CTNNB1 Foundation to support the development of URBAGEN — the world’s first gene therapy for CTNNB1 Syndrome. This is the first time a government has publicly backed a nonprofit-led gene therapy at such an early stage. The

Slovenia Awards €1M to CTNNB1 Foundation – A Breakthrough for Rare Disease Treatment Read More »